Science Confirms Turmeric As Effective As 14 Drugs

No less than 54 studies indicate that curcumin can induce cancer cell death.

This is the reason why turmeric (that is its prime compound curcumin) is one of the most researched plants in existence today. Turmeric is the yellow powder made from the root of an East Indian plant, which is one of the components of yellow curry. It is also a little something used on its own for flavor enhancement.

What have turmeric studies revealed?

The medicinal properties of turmeric have been the subject of over 5,600 peer-reviewed and published biomedical studies.  In fact, the five-year long research project on this holy plant revealed over 600 potential applications for preventive and therapeutic purposes, as well as 175 distinct beneficial physiological effects.

The comprehensive database of 1,585 turmeric abstracts is a subject of further scholar study.

Why is turmeric getting undivided scientific attention?

The density of research performed on this remarkable spice suggests that it compares favorably with a variety of conventional medications in use, including:

1. Lipitor/Atorvastatin(cholesterol medication):

A 2008 study published in the journal Drugs in R & D found that a standardized preparation of curcuminoids from Turmeric compared favorably with the drug atorvastatin (trade name Lipitor) on endothelial dysfunction, the underlying pathology of the blood vessels that drives atherosclerosis, in association with reductions in inflammation and oxidative stress in type 2 diabetic patients. 

2. Corticosteroids (steroid medications): 

A 1999 study published in the journal Phytotherapy Research found that the primary polyphenol in turmeric, the saffron colored pigment known as curcumin (saffron is a bright orange-yellow color), compared favorably with steroids in the management of chronic anterior uveitis, an inflammatory eye disease.

A 2008 study published in Critical Care Medicine found that curcumin compared favorably with the corticosteroid drug dexamethasone in the animal model as an alternative therapy for protecting lung transplantation-associated injury by down-regulating inflammatory genes. An earlier 2003 study published in Cancer Letters found the same drug also compared favorably with dexamethasone in a lung ischaemia-repurfusion injury model. 

3. Prozac/Fluoxetine & Imipramine (antidepressants):

 A 2011 study published in the journal Acta Poloniae Pharmaceutica found that curcumin compared favorably with both drugs in reducing depressive behavior in an animal model.

4. Aspirin (blood thinner):

A 1986 in vitro and ex vivo study published in the journal Arzneimittelforschung found that curcumin has anti-platelet and prostacyclin modulating effects compared with aspirin, indicating it may have value in patients prone to vascular thrombosis and requiring anti-arthritis therapy.

515151115

5. Anti-inflammatory drugs:

A 2004 study published in the journal Oncogene found that curcumin (as well as resveratrol) were effective alternatives to the drugs aspirin, ibuprofen, sulindac, phenylbutazone, naproxen, indomethacin, diclofenac, dexamethasone, celecoxib, and tamoxifen in exerting anti-inflammatory and anti-proliferative activity against tumor cells.

6. Oxaliplatin (chemotherapy drug):

A 2007 study published in the International Journal of Cancer found that curcumin compares favorably with oxaliplatin as an antiproliferative agent in colorectal cell lines.

7. Metformin (diabetes drug):

A 2009 study published in the journal Biochemistry and Biophysical Research Community explored how curcumin might be valuable in treating diabetes, finding that it activates AMPK (which increases glucose uptake) and suppresses gluconeogenic gene expression  (which suppresses glucose production in the liver) in hepatoma cells.

Interestingly, they found curcumin to be 500 times to 100,000 times (in the form known as tetrahydrocurcuminoids(THC)) more potent than metformin in activating AMPK and its downstream target acetyl-CoA carboxylase (ACC). 

Considering how strong curative record turmeric has, having been used as both food and medicine in a wide range of cultures for thousands of years, a strong argument can be made for using curcumin as a drug alternative (or adjuvant) in cancer treatment.  

Curcumin inhibits the growth of a number of cancers such as colon, prostate, ovarian, breast and brain cancer. It also inhibits the growth of new blood vessels that feed the tumor!

Turmeric’s anti-inflammatory properties are incredibly powerful. In fact, no other food ingredient is more effective at decreasing inflammation in the body.

Or, better yet, use certified organic (non-irradiated) turmeric in lower culinary doses on a daily basis so that heroic doses won’t be necessary later in life when a serious disease sets in. 

Nourishing yourselves, rather than self-medicating with ‘nutraceuticals,’ should be the goal of your diet of life!